# ICAR

Source: https://en.bioecon.ru/companies/icar/
Updated: 2026-06-24

- Country: India

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | INR 397.72 billion establishment expenses, INR 7.15 billion research and operational expenses (FY 2024-25) | https://www.icar.gov.in/sites/default/files/2025-11/Final%20Annual%20Accounts%202024-25_0.pdf |
| Revenue | INR 1.098 billion from sales/service (FY 2024-25) | https://www.icar.gov.in/sites/default/files/2025-11/Final%20Annual%20Accounts%202024-25_0.pdf |
| Headcount | Approximately 19,200 employees | https://icar.gov.in/sites/default/files/2022-06/HRM-Initiatives-of-ICAR-for-web-Final.pdf |
| Production site | ICAR manages 101 institutes and an extensive network of research centers across India | https://icar.org.in/sites/default/files/inline-files/Organization-Management-22.pdf, https://www.frontiersin.org/journals/agronomy/articles/10.3389/fagro.2025.1663528/full |
| Certification | ICAR manages intellectual property (IP) protection, including patents, plant variety rights, trademarks, and copyrights | https://sansad.in/getFile/lsapps/loksabhaquestions/annex/188/AU3714_3wr1un.pdf, https://www.icar.org.in/index.php/en/intellectual-property-technology-management-iptm-unit |
| Regulatory approval | ICAR works with the Genetic Engineering Appraisal Committee (GEAC) for regulatory approvals of genetically modified crops and genome-edited varieties | https://pmc.ncbi.nlm.nih.gov/articles/PMC12696234/, https://sansad.in/getFile/lsapps/loksabhaquestions/annex/188/AU3714_3wr1un.pdf |

Independent sources: frontiersin.org, pmc.ncbi.nlm.nih.gov, sansad.in

## Technologies

- [Allelopathic crops](https://en.bioecon.ru/technology/allelopathic-crops/)